News
Prof Kelly Chibale is passionate about improving the treatment outcomes of African patients. Read more about why and how his group is understanding drug metabolism in the African population.
Prof Kelly Chibale, founder and director of H3D, was recently interviewed by Chemistry World on his views on leadership, teamwork and his love for science. Read the full article here
Prof Kelly Chibale published an article in the Medicine Maker on how African Pharma has a promising role in changing the afro-pessimistic sentiment, so that we may begin to attract and retain skilled African scientists.
Prof Kelly Chibale published an article in the Daily Maverick on how the Oxford Vaccine Trial is an opportunity for African scientists to lead, earn respect & credibility, and show that Africans can be at the forefront of clinical trial research.